A practical reference on reconstitution: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-12-04 and is reviewed periodically as new material appears.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilised powder | Reconstitution is required before use in most assays |
| Solubility class | Freely soluble in water and acetonitrile; sparingly soluble in nonpolar solvents | Aqueous solutions may benefit from slight acidification |
| Typical storage temperature | -20 °C or lower, desiccated and protected from light | Short-term transport at 2-8 °C is common practice |
| Primary degradation routes | Oxidation, hydrolysis, aggregation | Tryptophan and histidine residues are the main oxidation targets |
| Quality marker | Chromatographic purity by peak area | Does not capture counter-ion content or residual solvents |
Solid peptide kept dry at minus twenty degrees Celsius, shielded from light and moisture, is generally considered stable for extended periods. Solutions are divided into single-use aliquots and held at minus twenty or minus eighty degrees Celsius, because repeated freeze-thaw cycles promote aggregation and loss of material to container surfaces. Hydrolysis of the backbone and oxidation of tryptophan are the principal degradation routes in aqueous solution, and both accelerate at ambient temperature. Hygroscopic uptake after a vial is opened can also shift the actual mass weighed, which affects any concentration calculated from it.
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
22 April 2016: Phua Han Chuan Jeffery, a Singaporean and chronic ketamine abuser who was arrested on 20 January 2010 for trafficking more than 100g of heroin into Singapore at Woodlands Checkpoint. He was found guilty and sentenced to death in September 2011. Phua, who lost his three previous appeals against the sentence between July 2012 to September 2015, was granted a re-trial two years and eight months after the government implemented new changes to the death penalty laws (in 2013). He was diagnosed to be suffering from persistent depressive disorder, and the condition, coupled with his chronic ketamine addiction, was argued by Phua's lawyers as sufficient to impair his mental responsibility at the time of the crime. The High Court accepted the defence's arguments and thus re-sentenced Phua, then 30 years old, to life-long incarceration on 22 April 2016, with his sentence backdated to the date of his remand. 27 April 2022: Nagaenthran K Dharmalingam, a Malaysian convicted of trafficking heroin in 2009 and sentenced to death in 2010. After changes to the law took effect in 2013, he applied for re-sentencing but had his application rejected. His appeals to the Court of Appeal were dismissed in 2019. In May 2019 he planned to appeal to the President of Singapore for clemency, but he lost his plea and his execution date was scheduled on 10 November 2021. However, Nagaenthran contracted COVID-19 while in prison and he also made an appeal, hence his execution was postponed and the appeal itself was also postponed twice.
=== Classification === A clinical severity score has been developed to assess chronic venous ulcers. It is based on the CEAP (clinical, etiology, anatomy, and pathophysiology) classification system developed by an expert panel. A high score gives a poor prognosis.
=== 1991 === January 1991 – Money transfers from the Czech Republic budget to the Slovak Republic are stopped, beginning the process that would lead to Velvet Divorce. February 28, 1991 – End of Gulf War. March 3, 1991 – Estonia and Latvia hold an independence referendum with a majority voting to restore independence. March 31, 1991 – Georgia holds an independence referendum resulting in a majority of Georgians voting in favour of Georgia becoming independent from the Soviet Union. May 1, 1991 – The Republic of China abolishes the Temporary Provisions against the Communist Rebellion which was in place during the Chinese Civil War. May 19, 1991 – Croatia holds an independence referendum resulting in a majority of Croatians voting in favour of Croatia seeking independence from Yugoslavia. May 24, 1991 – End of Eritrean War of Independence in Ethiopia. June 27, 1991 – Beginning of the Yugoslav Wars in Slovenia. June 28, 1991 – Comecon is dissolved. July 1, 1991 – The Warsaw Pact is dissolved. July 10, 1991 – Boris Yeltsin becomes president of Russia. July 31, 1991 – Ratification of START I treaty between United States and the Soviet Union. August 19, 1991 – Start of the Soviet Union coup d'état attempt. August 21, 1991 – The Soviet Union coup d'état is dissolved. August 24, 1991 – Gorbachev resigns from the post of General Secretary of the Communist Party of the Soviet Union. September 6, 1991 – The Soviet Union recognizes the independence of the Baltic States.
Sources: en.wikipedia.org
=== Distribution === In plasma, estradiol is largely bound to SHBG and albumin. Only about 2.21% (± 0.04%) of estradiol is free and biologically active. The percentage remains constant throughout the menstrual cycle.
Drug developers have focused on selective COX-2 inhibition, particularly as a way to minimize the gastrointestinal side effects of nonsteroidal anti-inflammatory drugs. However, the cardiovascular adverse effects of some COX-2 inhibitors has led to lawsuits alleging wrongful death by heart attack. Yet, other significantly COX-selective nonsteroidal anti-inflammatory drugs, such as diclofenac, have been well tolerated by most of the population. Besides the COX-inhibition, several other molecular targets of diclofenac possibly contributing to its pain-relieving actions have recently been identified. These include:
=== Icelandic === Icelandic has the ability to form compounds of arbitrary length by stringing together genitives (eignarfallssamsetning), so no single words of maximal length exist in the language. However, vaðlaheiðarvegavinnuverkfærageymsluskúr and vaðlaheiðarvegavinnuverkfærageymsluskúraútidyralyklakippuhringur are sometimes cited as particularly long words; the latter has 64 letters and means "a keychain ring for the outdoor key of road workers shed in a moor called Vaðlaheiði". Analysis of a corpus of contemporary Icelandic texts by Uwe Quasthoff, Sabine Fiedler and Erla Hallsteinsdóttir identified Alþjóðaflutningaverkamannasambandsins ("of the International Transport Workers' Federation"; 37 letters) and Norðvestur-Atlantshafsfiskveiðistofnunarinnar ("of the Northwest Atlantic Fisheries' Organization"; 45 letters) as the longest unhyphenated and hyphenated words. The longest word occurring at least twice in the University of Leipzig isl-is_web_2015 corpus is Auðmannastjórnvaldaembættisstjórnmálaverkalýðsverðlausraverðbréfaábyrgðarlausrakvóta-ræningjaaftaníossaspilling (110 letters).
The East Central Conference is a former high school athletic conference in Wisconsin. Originally founded in 1970, it was disbanded in 2001 and remained defunct until its reconstitution in 2015. It lasted for ten seasons before a second dissolution in 2025, and all members in both incarnations belonged to the Wisconsin Interscholastic Athletic Association.
Sources: en.wikipedia.org
Solutions are best kept cold, protected from light, and buffered to a pH that limits hydrolysis. Dividing a stock into single-use aliquots avoids repeated freeze-thaw cycles, which measurably reduce the intact parent peak over time.
Reversed-phase chromatography establishes a purity profile, while electrospray or matrix-assisted laser desorption mass spectrometry confirms that the observed mass matches the expected sequence. Together they support, but do not fully prove, identity and purity.
Reviews generally characterise it as thin, dominated by small and often uncontrolled studies. Several authors explicitly note that findings on pigmentation, appetite and sexual function have not been confirmed in adequately powered controlled trials.
Low temperature slows hydrolysis and oxidation, the two main routes by which the peptide backbone and side chains are modified. A lyophilised powder stored at −20 °C is more stable than one kept at room temperature, and once the material is dissolved the degradation rate rises, making refrigeration more important.